Cargando…
Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020778/ https://www.ncbi.nlm.nih.gov/pubmed/27651715 http://dx.doi.org/10.4103/0976-500X.189688 |
_version_ | 1782453263938879488 |
---|---|
author | Pal, Sutanaya Pinto, Ekta Franscina Raut, Nitin B. Banwari, Girish Andrade, Chittaranjan |
author_facet | Pal, Sutanaya Pinto, Ekta Franscina Raut, Nitin B. Banwari, Girish Andrade, Chittaranjan |
author_sort | Pal, Sutanaya |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5020778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-50207782016-09-20 Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods Pal, Sutanaya Pinto, Ekta Franscina Raut, Nitin B. Banwari, Girish Andrade, Chittaranjan J Pharmacol Pharmacother Correspondence Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC5020778/ /pubmed/27651715 http://dx.doi.org/10.4103/0976-500X.189688 Text en Copyright: © Journal of Pharmacology and Pharmacotherapeutics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Correspondence Pal, Sutanaya Pinto, Ekta Franscina Raut, Nitin B. Banwari, Girish Andrade, Chittaranjan Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods |
title | Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods |
title_full | Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods |
title_fullStr | Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods |
title_full_unstemmed | Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods |
title_short | Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods |
title_sort | randomized controlled comparison of agomelatine and escitalopram: concerns about study design and methods |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020778/ https://www.ncbi.nlm.nih.gov/pubmed/27651715 http://dx.doi.org/10.4103/0976-500X.189688 |
work_keys_str_mv | AT palsutanaya randomizedcontrolledcomparisonofagomelatineandescitalopramconcernsaboutstudydesignandmethods AT pintoektafranscina randomizedcontrolledcomparisonofagomelatineandescitalopramconcernsaboutstudydesignandmethods AT rautnitinb randomizedcontrolledcomparisonofagomelatineandescitalopramconcernsaboutstudydesignandmethods AT banwarigirish randomizedcontrolledcomparisonofagomelatineandescitalopramconcernsaboutstudydesignandmethods AT andradechittaranjan randomizedcontrolledcomparisonofagomelatineandescitalopramconcernsaboutstudydesignandmethods |